There were 448 press releases posted in the last 24 hours and 221,634 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
AVM Biotechnology Announces Full Enrollment of First Cohort of Relapsed/Refractory Non-Hodgkin’s Lymphoma Patients

TO:
Jena Dalpez
AVM Biotechnology
+ 12069069922

FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image